ALERT: Your health is top priority. We’re committed to providing reliable COVID-19 resources to keep you informed and safe.

First Talc Verdict of 2019: Jury Awards $29.4M in Mesothelioma Case


Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Judge Striking Gavel

A California jury ordered Johnson & Johnson to pay $24.4 million to a dying woman who says she developed mesothelioma after being exposed to asbestos in the company’s talcum powder. The jury awarded an additional $5 million to her spouse.

Teresa “Terry” Leavitt, who was 52 years old at the time of her diagnosis, is a mother of two from Fremont, California. Her lawsuit says she used Johnson & Johnson’s talc products for 20 years, beginning when she was a baby and her mother sprinkled it on her. She continued to use it as a makeup base and dry shampoo throughout her teenage years and as a young adult.

In 2017, doctors diagnosed Leavitt with mesothelioma, a rare and lethal cancer that attacks the lining of the lungs and other organs. Asbestos exposure is the leading cause of mesothelioma. Leavitt is not expected to live past 2020, according to news reports.

Dr. Jerrold Abraham, a New York pathologist, was a key witness for Leavitt during the two-month trial. Abraham testified that he’d found evidence of asbestos fibers in Leavitt’s tissue samplings and concluded that baby powder exposure caused her disease.

Lawyers for Johnson & Johnson argued that Leavitt’s mesothelioma was idiopathic, or occurred spontaneously. Their top witness was John Hopkins, a British toxicologist who once worked in research and development for Johnson & Johnson. Hopkins said the company exhaustively tested their talcum powder to ensure it was free of asbestos contamination.

After two days of deliberation, the jury decided Johnson & Johnson’s talcum powder had been contaminated with asbestos and was a “substantial contributing factor” to Leavitt’s illness. Jurors said the company’s failure to warn consumers of the potential risks had harmed Leavitt.

Talc Gets Congressional Scrutiny

The March 13 verdict came a day after the House Subcommittee on Economic and Consumer Policy held public hearings on the potential cancer risks associated with talcum powder and other consumer products.

Dr. Anne McTiernan, a cancer prevention researcher with the Fred Hutchinson Cancer Research Center in Seattle, told lawmakers that women need to know about the risks of using talcum powder in their genital areas.

She noted epidemiologic studies show use of talcum powder products in a woman’s genital area increased their risk of developing epithelial ovarian cancer by 22 percent to 31 percent. “All consumers need to be warned about the contents of these products, including asbestos and fibrous talc, so that they can make informed decisions about use,” McTiernan said.

The Congressional subcommittee also questioned Johnson & Johnson’s historical marketing practices, which included targeting minorities to increase sales of Johnson’s Baby Powder. A recent Drugwatch feature explains how Johnson & Johnson used these and other aggressive marketing techniques to perpetuate myths about feminine hygiene and, in doing so, may have fueled an ovarian cancer crisis.

Diagnosed with cancer after talcum powder use? Get a Free Case Review

Thousands More Talcum Powder Lawsuits Pending

Leavitt’s case is the latest of thousands of talcum powder lawsuits pending against Johnson & Johnson and was the first of more than a dozen set to go to trial in 2019.

The verdict marks the seventh time Johnson & Johnson has lost a trial over claims that it “hid health risks” associated with its talc products, according to Bloomberg.

It’s also the first court loss for the company since July 2018, when a Missouri jury awarded $4.69 billion to 22 women who blamed their ovarian cancer diagnoses on longtime use of Johnson’s Baby Powder. That case also centered around claims that the talcum powder was contaminated with asbestos.

Johnson & Johnson, meanwhile, has said it plans to appeal the Leavitt case. The company’s lawyers argued that the trial should have ended in a mistrial because of alleged procedural and evidentiary errors. The company maintains that its talc products are safe and free of asbestos.

Nurse Amy Keller
Written By Amy Keller, RN Registered Nurse

Amy Keller is a registered nurse and award-winning journalist with 22 years of experience writing about politics, business, health and other topics. At Drugwatch, she draws on her clinical experience and investigative reporting skills to write about consumers’ health concerns such as the safety of online pharmacies. She also provides informed analysis on complex health issues. Some of her qualifications include:

  • Recipient of USF’s Nurse Alumni Nightingale award for excellence in nursing
  • Guest Faculty Speaker, “Moving Forward with Patient- and Family-Centered Care Intensive Training Seminar”
  • Member of Sigma Theta Tau International Honor Society of Nursing
Edited By
Emily Miller
Emily Miller Managing Editor

12 Cited Research Articles writers follow rigorous sourcing guidelines and cite only trustworthy sources of information, including peer-reviewed journals, court records, academic organizations, highly regarded nonprofit organizations, government reports and interviews with qualified experts. Review our editorial policy to learn more about our process for producing accurate, current and balanced content.

  1. ALM Media. (2019, March 13). California Jury Hits J&J With $29 M Talc Verdict. Retrieved from
  2. Christensen, J. (2019, March 12). Talc cancer concerns get their day in Congress. Retrieved from
  3. Committee on Oversight and Reform. Hearing Recap: Subcommittee on Economic and Consumer Policy Examined the Public Health Risks of Carcinogens in Consumer Products. Retrieved from
  4. Feeley, J., Burnson, R. & Fisk, M.C. (2019, March 13). J&J Must Pay $29 Million Over Woman’s Talc-Linked Cancer. Retrieved from
  5. Girion, L. (2018, December 14). Johnson & Johnson knew for decades that asbestos lurked in its Baby Powder. Retrieved from
  6. Hsu, T. (2019, March 14). Johnson & Johnson Hit With $29 Million Verdict in case Over Talc and Asbestos. Retrieved from
  7. Sammon, J. (2019, January 16). Fifth day at talc trial, sides continue to spar over cause of woman’s mesothelioma. Retrieved from
  8. Sammon, J. (2019, March 13). Jury finds Johnson & Johnson liable for $29.4 million in woman’s mesothelioma suit. Retrieved from
  9. Sammon, J. (2019, January 18). Plaintiff witness discusses asbestos fibers in ongoing talcum powder trial. Retrieved from
  10. Siegel, D. (2019, March 13). California Jury Hits Johnson & Johnson With $29M+ Verdict In Latest Talc/Mesothelioma Trial. Retrieved from
  11. House Committee on Oversight and Reform. (2019, March 12). Statement of Dr. Ann McTiernan. Retrieved from
  12. Teresa Elizabeth Leavitt and Dean J. McElroy v. Johnson & Johnson, et al. (2017, November 14). Superior Court of California County of Alameda. Retrieved from
View All Sources
Call to speak with a legal expert
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's trusted legal partners support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our partners page.

(855) 547-5876